On Tuesday, Viridian Therapeutics Inc (NASDAQ: VRDN) was -0.67% drop from the session before settling in for the closing price of $17.98. A 52-week range
Viridian Therapeutics Inc (NASDAQ: VRDN) flaunted slowness of -3.07% at $19.24, before settling in for the price of $19.85 at the close. Taking a more
Viridian Therapeutics Inc (NASDAQ: VRDN) established initial surge of 1.15% at $19.43, before settling in for the price of $19.21 at the close. Taking a
A new trading day began on Tuesday, with Viridian Therapeutics Inc (NASDAQ: VRDN) stock price down -5.12% from the previous day of trading, before settling
Witnessing the stock’s movement on the chart, on Wednesday, Viridian Therapeutics Inc (NASDAQ: VRDN) had a quiet start as it plunged -8.42% to $19.15, before
Viridian Therapeutics Inc (NASDAQ: VRDN) established initial surge of 3.08% at $19.76, before settling in for the price of $19.17 at the close. Taking a
Viridian Therapeutics Inc (NASDAQ: VRDN) kicked off on Monday, up 3.36% from the previous trading day, before settling in for the closing price of $19.03.
Viridian Therapeutics Inc (NASDAQ: VRDN) open the trading on Wednesday, with a bit cautious approach as it glided -9.08% to $18.93, before settling in for
A new trading day began on Friday, with Viridian Therapeutics Inc (NASDAQ: VRDN) stock price down -0.78% from the previous day of trading, before settling
Viridian Therapeutics Inc (NASDAQ: VRDN) kicked off on Tuesday, down -0.87% from the previous trading day, before settling in for the closing price of $19.53.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
